nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—Nasal discomfort—Fluorouracil—head and neck cancer	0.0383	0.0391	CcSEcCtD
Travoprost—Scab—Fluorouracil—head and neck cancer	0.0344	0.0352	CcSEcCtD
Travoprost—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.0256	0.0261	CcSEcCtD
Travoprost—Peptic ulcer—Vinblastine—head and neck cancer	0.025	0.0255	CcSEcCtD
Travoprost—Photopsia—Docetaxel—head and neck cancer	0.0249	0.0254	CcSEcCtD
Travoprost—Blepharitis—Hydroxyurea—head and neck cancer	0.0247	0.0253	CcSEcCtD
Travoprost—Tafluprost—PTGS2—head and neck cancer	0.0206	1	CrCbGaD
Travoprost—Lacrimation—Fluorouracil—head and neck cancer	0.0186	0.019	CcSEcCtD
Travoprost—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.0184	0.0188	CcSEcCtD
Travoprost—Blepharitis—Fluorouracil—head and neck cancer	0.0178	0.0182	CcSEcCtD
Travoprost—Tenderness—Hydroxyurea—head and neck cancer	0.0174	0.0178	CcSEcCtD
Travoprost—Photophobia—Vinblastine—head and neck cancer	0.0157	0.016	CcSEcCtD
Travoprost—Lacrimation—Docetaxel—head and neck cancer	0.0134	0.0137	CcSEcCtD
Travoprost—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.0133	0.0136	CcSEcCtD
Travoprost—Eye irritation—Fluorouracil—head and neck cancer	0.0128	0.0131	CcSEcCtD
Travoprost—Tenderness—Fluorouracil—head and neck cancer	0.0126	0.0128	CcSEcCtD
Travoprost—Lacrimation increased—Fluorouracil—head and neck cancer	0.0119	0.0121	CcSEcCtD
Travoprost—Herpes simplex—Fluorouracil—head and neck cancer	0.0119	0.0121	CcSEcCtD
Travoprost—Inflammation—Fluorouracil—head and neck cancer	0.0113	0.0115	CcSEcCtD
Travoprost—Dermatitis contact—Fluorouracil—head and neck cancer	0.0108	0.011	CcSEcCtD
Travoprost—Dermatitis atopic—Docetaxel—head and neck cancer	0.0107	0.0109	CcSEcCtD
Travoprost—Scotoma—Docetaxel—head and neck cancer	0.0104	0.0106	CcSEcCtD
Travoprost—Photophobia—Fluorouracil—head and neck cancer	0.0103	0.0105	CcSEcCtD
Travoprost—Angina pectoris—Vinblastine—head and neck cancer	0.0102	0.0104	CcSEcCtD
Travoprost—Depression—Vinblastine—head and neck cancer	0.0093	0.0095	CcSEcCtD
Travoprost—Eye irritation—Docetaxel—head and neck cancer	0.00926	0.00945	CcSEcCtD
Travoprost—Dysuria—Hydroxyurea—head and neck cancer	0.00892	0.00911	CcSEcCtD
Travoprost—Bone disorder—Docetaxel—head and neck cancer	0.00875	0.00893	CcSEcCtD
Travoprost—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00869	0.00887	CcSEcCtD
Travoprost—Lacrimation increased—Docetaxel—head and neck cancer	0.00858	0.00876	CcSEcCtD
Travoprost—Infestation NOS—Hydroxyurea—head and neck cancer	0.00851	0.00869	CcSEcCtD
Travoprost—Infestation—Hydroxyurea—head and neck cancer	0.00851	0.00869	CcSEcCtD
Travoprost—Pharyngitis—Vinblastine—head and neck cancer	0.00831	0.00849	CcSEcCtD
Travoprost—Inflammation—Docetaxel—head and neck cancer	0.00815	0.00832	CcSEcCtD
Travoprost—Blood pressure increased—Docetaxel—head and neck cancer	0.0079	0.00807	CcSEcCtD
Travoprost—Angiopathy—Hydroxyurea—head and neck cancer	0.00693	0.00708	CcSEcCtD
Travoprost—Ill-defined disorder—Vinblastine—head and neck cancer	0.00677	0.00691	CcSEcCtD
Travoprost—Angina pectoris—Fluorouracil—head and neck cancer	0.00669	0.00683	CcSEcCtD
Travoprost—Erythema—Hydroxyurea—head and neck cancer	0.00665	0.00679	CcSEcCtD
Travoprost—Malaise—Vinblastine—head and neck cancer	0.00658	0.00671	CcSEcCtD
Travoprost—Vertigo—Vinblastine—head and neck cancer	0.00655	0.00669	CcSEcCtD
Travoprost—Hypertension—Vinblastine—head and neck cancer	0.0063	0.00643	CcSEcCtD
Travoprost—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00617	0.0063	CcSEcCtD
Travoprost—Discomfort—Vinblastine—head and neck cancer	0.00613	0.00626	CcSEcCtD
Travoprost—Infestation NOS—Fluorouracil—head and neck cancer	0.00613	0.00625	CcSEcCtD
Travoprost—Infestation—Fluorouracil—head and neck cancer	0.00613	0.00625	CcSEcCtD
Travoprost—Malaise—Hydroxyurea—head and neck cancer	0.006	0.00612	CcSEcCtD
Travoprost—Conjunctivitis—Fluorouracil—head and neck cancer	0.00595	0.00608	CcSEcCtD
Travoprost—Urinary tract infection—Fluorouracil—head and neck cancer	0.00595	0.00608	CcSEcCtD
Travoprost—Sinusitis—Fluorouracil—head and neck cancer	0.00575	0.00587	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00562	0.00574	CcSEcCtD
Travoprost—Discomfort—Hydroxyurea—head and neck cancer	0.00559	0.00571	CcSEcCtD
Travoprost—Rhinitis—Fluorouracil—head and neck cancer	0.00551	0.00563	CcSEcCtD
Travoprost—Pharyngitis—Fluorouracil—head and neck cancer	0.00546	0.00557	CcSEcCtD
Travoprost—Oedema—Hydroxyurea—head and neck cancer	0.00543	0.00554	CcSEcCtD
Travoprost—Infection—Hydroxyurea—head and neck cancer	0.00539	0.00551	CcSEcCtD
Travoprost—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00532	0.00543	CcSEcCtD
Travoprost—Skin disorder—Hydroxyurea—head and neck cancer	0.00527	0.00538	CcSEcCtD
Travoprost—Pain—Vinblastine—head and neck cancer	0.00509	0.0052	CcSEcCtD
Travoprost—Constipation—Vinblastine—head and neck cancer	0.00509	0.0052	CcSEcCtD
Travoprost—Feeling abnormal—Vinblastine—head and neck cancer	0.0049	0.00501	CcSEcCtD
Travoprost—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00487	0.00497	CcSEcCtD
Travoprost—Dyspnoea—Hydroxyurea—head and neck cancer	0.00484	0.00494	CcSEcCtD
Travoprost—Angina pectoris—Docetaxel—head and neck cancer	0.00483	0.00493	CcSEcCtD
Travoprost—Erythema—Fluorouracil—head and neck cancer	0.00479	0.00489	CcSEcCtD
Travoprost—Dyspepsia—Hydroxyurea—head and neck cancer	0.00478	0.00488	CcSEcCtD
Travoprost—Abdominal pain—Vinblastine—head and neck cancer	0.0047	0.0048	CcSEcCtD
Travoprost—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00469	0.00478	CcSEcCtD
Travoprost—Fatigue—Hydroxyurea—head and neck cancer	0.00468	0.00478	CcSEcCtD
Travoprost—Constipation—Hydroxyurea—head and neck cancer	0.00464	0.00474	CcSEcCtD
Travoprost—Pain—Hydroxyurea—head and neck cancer	0.00464	0.00474	CcSEcCtD
Travoprost—Vision blurred—Fluorouracil—head and neck cancer	0.00451	0.00461	CcSEcCtD
Travoprost—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00447	0.00457	CcSEcCtD
Travoprost—Infestation NOS—Docetaxel—head and neck cancer	0.00442	0.00451	CcSEcCtD
Travoprost—Infestation—Docetaxel—head and neck cancer	0.00442	0.00451	CcSEcCtD
Travoprost—Hypersensitivity—Vinblastine—head and neck cancer	0.00438	0.00448	CcSEcCtD
Travoprost—Conjunctivitis—Docetaxel—head and neck cancer	0.0043	0.00439	CcSEcCtD
Travoprost—Asthenia—Vinblastine—head and neck cancer	0.00427	0.00436	CcSEcCtD
Travoprost—Myalgia—Fluorouracil—head and neck cancer	0.00408	0.00416	CcSEcCtD
Travoprost—Chest pain—Fluorouracil—head and neck cancer	0.00408	0.00416	CcSEcCtD
Travoprost—Diarrhoea—Vinblastine—head and neck cancer	0.00407	0.00416	CcSEcCtD
Travoprost—Discomfort—Fluorouracil—head and neck cancer	0.00403	0.00411	CcSEcCtD
Travoprost—Hypersensitivity—Hydroxyurea—head and neck cancer	0.004	0.00408	CcSEcCtD
Travoprost—Rhinitis—Docetaxel—head and neck cancer	0.00398	0.00406	CcSEcCtD
Travoprost—Pharyngitis—Docetaxel—head and neck cancer	0.00394	0.00402	CcSEcCtD
Travoprost—Dizziness—Vinblastine—head and neck cancer	0.00394	0.00402	CcSEcCtD
Travoprost—Urinary tract disorder—Docetaxel—head and neck cancer	0.00392	0.004	CcSEcCtD
Travoprost—Oedema—Fluorouracil—head and neck cancer	0.00391	0.00399	CcSEcCtD
Travoprost—Connective tissue disorder—Docetaxel—head and neck cancer	0.0039	0.00398	CcSEcCtD
Travoprost—Asthenia—Hydroxyurea—head and neck cancer	0.00389	0.00398	CcSEcCtD
Travoprost—Urethral disorder—Docetaxel—head and neck cancer	0.00389	0.00397	CcSEcCtD
Travoprost—Infection—Fluorouracil—head and neck cancer	0.00388	0.00396	CcSEcCtD
Travoprost—Nervous system disorder—Fluorouracil—head and neck cancer	0.00383	0.00391	CcSEcCtD
Travoprost—Visual impairment—Docetaxel—head and neck cancer	0.00382	0.00391	CcSEcCtD
Travoprost—Tachycardia—Fluorouracil—head and neck cancer	0.00381	0.00389	CcSEcCtD
Travoprost—Headache—Vinblastine—head and neck cancer	0.00373	0.00381	CcSEcCtD
Travoprost—Diarrhoea—Hydroxyurea—head and neck cancer	0.00371	0.00379	CcSEcCtD
Travoprost—Eye disorder—Docetaxel—head and neck cancer	0.00371	0.00379	CcSEcCtD
Travoprost—Cardiac disorder—Docetaxel—head and neck cancer	0.00368	0.00376	CcSEcCtD
Travoprost—Hypotension—Fluorouracil—head and neck cancer	0.00365	0.00373	CcSEcCtD
Travoprost—Angiopathy—Docetaxel—head and neck cancer	0.0036	0.00368	CcSEcCtD
Travoprost—Dizziness—Hydroxyurea—head and neck cancer	0.00359	0.00366	CcSEcCtD
Travoprost—Immune system disorder—Docetaxel—head and neck cancer	0.00358	0.00366	CcSEcCtD
Travoprost—Mediastinal disorder—Docetaxel—head and neck cancer	0.00358	0.00365	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00356	0.00363	CcSEcCtD
Travoprost—Nausea—Vinblastine—head and neck cancer	0.00354	0.00361	CcSEcCtD
Travoprost—Dyspnoea—Fluorouracil—head and neck cancer	0.00348	0.00356	CcSEcCtD
Travoprost—Mental disorder—Docetaxel—head and neck cancer	0.00348	0.00355	CcSEcCtD
Travoprost—Erythema—Docetaxel—head and neck cancer	0.00345	0.00353	CcSEcCtD
Travoprost—Dyspepsia—Fluorouracil—head and neck cancer	0.00344	0.00351	CcSEcCtD
Travoprost—Rash—Hydroxyurea—head and neck cancer	0.00342	0.00349	CcSEcCtD
Travoprost—Dermatitis—Hydroxyurea—head and neck cancer	0.00342	0.00349	CcSEcCtD
Travoprost—Headache—Hydroxyurea—head and neck cancer	0.0034	0.00347	CcSEcCtD
Travoprost—Dysgeusia—Docetaxel—head and neck cancer	0.00338	0.00345	CcSEcCtD
Travoprost—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00337	0.00344	CcSEcCtD
Travoprost—Back pain—Docetaxel—head and neck cancer	0.00334	0.00341	CcSEcCtD
Travoprost—Pain—Fluorouracil—head and neck cancer	0.00334	0.00341	CcSEcCtD
Travoprost—Nausea—Hydroxyurea—head and neck cancer	0.00322	0.00329	CcSEcCtD
Travoprost—Feeling abnormal—Fluorouracil—head and neck cancer	0.00322	0.00329	CcSEcCtD
Travoprost—Palpitations—Docetaxel—head and neck cancer	0.00305	0.00312	CcSEcCtD
Travoprost—Cough—Docetaxel—head and neck cancer	0.00301	0.00308	CcSEcCtD
Travoprost—Hypertension—Docetaxel—head and neck cancer	0.00298	0.00305	CcSEcCtD
Travoprost—Arthralgia—Docetaxel—head and neck cancer	0.00294	0.003	CcSEcCtD
Travoprost—Chest pain—Docetaxel—head and neck cancer	0.00294	0.003	CcSEcCtD
Travoprost—Myalgia—Docetaxel—head and neck cancer	0.00294	0.003	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00292	0.00298	CcSEcCtD
Travoprost—Hypersensitivity—Fluorouracil—head and neck cancer	0.00288	0.00294	CcSEcCtD
Travoprost—Dry mouth—Docetaxel—head and neck cancer	0.00288	0.00294	CcSEcCtD
Travoprost—Oedema—Docetaxel—head and neck cancer	0.00282	0.00288	CcSEcCtD
Travoprost—Infection—Docetaxel—head and neck cancer	0.0028	0.00286	CcSEcCtD
Travoprost—Nervous system disorder—Docetaxel—head and neck cancer	0.00277	0.00282	CcSEcCtD
Travoprost—Pruritus—Fluorouracil—head and neck cancer	0.00276	0.00282	CcSEcCtD
Travoprost—Tachycardia—Docetaxel—head and neck cancer	0.00275	0.00281	CcSEcCtD
Travoprost—Skin disorder—Docetaxel—head and neck cancer	0.00274	0.0028	CcSEcCtD
Travoprost—Diarrhoea—Fluorouracil—head and neck cancer	0.00267	0.00273	CcSEcCtD
Travoprost—Hypotension—Docetaxel—head and neck cancer	0.00263	0.00269	CcSEcCtD
Travoprost—Dizziness—Fluorouracil—head and neck cancer	0.00258	0.00264	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00257	0.00262	CcSEcCtD
Travoprost—Dyspnoea—Docetaxel—head and neck cancer	0.00251	0.00257	CcSEcCtD
Travoprost—Dyspepsia—Docetaxel—head and neck cancer	0.00248	0.00253	CcSEcCtD
Travoprost—Rash—Fluorouracil—head and neck cancer	0.00246	0.00251	CcSEcCtD
Travoprost—Dermatitis—Fluorouracil—head and neck cancer	0.00246	0.00251	CcSEcCtD
Travoprost—Headache—Fluorouracil—head and neck cancer	0.00245	0.0025	CcSEcCtD
Travoprost—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00243	0.00249	CcSEcCtD
Travoprost—Fatigue—Docetaxel—head and neck cancer	0.00243	0.00248	CcSEcCtD
Travoprost—Pain—Docetaxel—head and neck cancer	0.00241	0.00246	CcSEcCtD
Travoprost—Constipation—Docetaxel—head and neck cancer	0.00241	0.00246	CcSEcCtD
Travoprost—Feeling abnormal—Docetaxel—head and neck cancer	0.00232	0.00237	CcSEcCtD
Travoprost—Nausea—Fluorouracil—head and neck cancer	0.00232	0.00237	CcSEcCtD
Travoprost—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00231	0.00235	CcSEcCtD
Travoprost—Abdominal pain—Docetaxel—head and neck cancer	0.00223	0.00228	CcSEcCtD
Travoprost—Hypersensitivity—Docetaxel—head and neck cancer	0.00208	0.00212	CcSEcCtD
Travoprost—Asthenia—Docetaxel—head and neck cancer	0.00202	0.00207	CcSEcCtD
Travoprost—Pruritus—Docetaxel—head and neck cancer	0.00199	0.00204	CcSEcCtD
Travoprost—Diarrhoea—Docetaxel—head and neck cancer	0.00193	0.00197	CcSEcCtD
Travoprost—Dizziness—Docetaxel—head and neck cancer	0.00186	0.0019	CcSEcCtD
Travoprost—Rash—Docetaxel—head and neck cancer	0.00178	0.00182	CcSEcCtD
Travoprost—Dermatitis—Docetaxel—head and neck cancer	0.00178	0.00181	CcSEcCtD
Travoprost—Headache—Docetaxel—head and neck cancer	0.00177	0.0018	CcSEcCtD
Travoprost—Nausea—Docetaxel—head and neck cancer	0.00167	0.00171	CcSEcCtD
